Impax Laboratories, LLC
20 clinical trials · Sponsor
◉ Watch Impax Laboratories, LLC
| Record | Firm | Date |
|---|---|---|
| A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease (NCT06765668) | Impax Laboratories, LLC | 2025-02-12 |
| A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects (NCT06161220) | Impax Laboratories, LLC | 2023-10-30 |
| Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in Parkinson's Disease (PD) Participants With Motor Fluctuations (NCT03877510) | Impax Laboratories, LLC | 2019-04-03 |
| A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations (NCT03670953) | Impax Laboratories, LLC | 2018-11-06 |
| Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE (NCT03275922) | Impax Laboratories, LLC | 2017-11-27 |
Track Impax Laboratories, LLC automatically
Every clearance here is in the API, with alerts when new ones post.